{"DataElement":{"publicId":"6260029","version":"1","preferredName":"FLT3 Internal Tandem Duplication Allele Ratio Laboratory Procedure Performed Outcome 2 Decimal Place Value","preferredDefinition":"The 2 decimal place numeric laboratory value measured, assigned or computed related to the FLT3-Internal Tandem Duplication high allelic ratio in a specimen.","longName":"5628500v1.0:2784513v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5628500","version":"1","preferredName":"FLT3 Internal Tandem Duplication Allele Ratio Laboratory Procedure Performed","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis._Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process._Quotient of quantities of the same kind for different components within the same system._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"5629181v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5629181","version":"1","preferredName":"FLT3 Internal Tandem Duplication Allele Ratio Laboratory Procedure","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.:one of a series of possible alternative forms of a given gene, differing in DNA sequence, and affecting the functioning of a single product.:Quotient of quantities of the same kind for different components within the same system.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C67494:C16277:C44256:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Internal Tandem Duplication","conceptCode":"C67494","definition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Allele","conceptCode":"C16277","definition":"Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"465EFEB0-270F-0255-E053-F662850AC01E","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-18","modifiedBy":"ONEDATA","dateModified":"2017-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4639B9FC-3F05-6B37-E053-F662850A4ABD","latestVersionIndicator":"Yes","beginDate":"2017-01-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-16","modifiedBy":"NYCHM","dateModified":"2017-08-31","changeDescription":"released 8/31/17mn.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2784513","version":"1","preferredName":"Laboratory Procedure Outcome Integer::2 Decimal Place Value","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Outcome; a phenomenon that follows and is caused by some previous phenomenon._A number with no fractional part, including the negative and positive numbers as well as zero.::2_An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers._A numerical quantity measured or assigned or computed.","longName":"LAB_PROC_OUT_2DP_VAL","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2784512","version":"1","preferredName":"Laboratory Procedure Outcome Integer::2 Decimal Place Value","preferredDefinition":"A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.:A number with no fractional part.::2:An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.:A numerical quantity measured or assigned or computed.","longName":"C25294:C20200:C45255::2:C42646","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Decimal Place","conceptCode":"C42646","definition":"An indication of the specific number of digits to be expected to the right of the decimal point in a line of numbers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F06815-3EB2-22EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"ONEDATA","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56F06815-3EC3-22EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-15","modifiedBy":"NYCHM","dateModified":"2010-11-23","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_AML_dx_flt3_itd_ratio_spe","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_AML_bet_flt3_itd_ratio_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_AML_le_flt3_itd_ratio_spe","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the value of the FLT3","type":"Preferred Question Text","description":"What is the value of the FLT3-Internal Tandem Duplication high allelic ratio?","url":null,"context":"NHLBI"},{"name":"Specify FLT3 - ITD allelic ratio:","type":"Alternate Question Text","description":"Specify FLT3 - ITD allelic ratio:","url":null,"context":"NHLBI"},{"name":"Specify FLT3 - ITD allelic ratio:","type":"Application Standard Question Text","description":"Specify FLT3 - ITD allelic ratio:","url":null,"context":"NHLBI"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Value","url":null,"context":"Theradex"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3A743A-06FA-0D22-E053-F662850A6FED","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":".System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}